Bayer Submits MRI Contrast Agent Gadoquatrane for FDA Review
If approved, gadoquatrane would become the lowest-dose macrocyclic gadolinium-based contrast agent available in the U.S. market.
MR/CT
Stay informed on state-of-the-art magnetic resonance and computed tomography. From ultra-high field imaging and AI-assisted reconstruction to spectral CT and functional MR, this category covers innovations that are pushing boundaries in speed, resolution, and diagnostic accuracy.
